Semaglutide-Associated Gastric Pneumatosis.

IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY

ACG Case Reports Journal Pub Date : 2024-12-27 eCollection Date: 2025-01-01 DOI:10.14309/crj.0000000000001579

Andrew M Turunen, Reilly A Coombs, Sushil Kumar Garg

引用次数: 0

Abstract

Semaglutide, a glucagon-like peptide-1 receptor agonist, used for Type 2 diabetes mellitus and more recently for weight loss, often causes gastrointestinal adverse effects such as delayed gastric emptying and abdominal discomfort. Current literature has not described an associated case of gastric pneumatosis with semaglutide use. We report a 61-year-old man on semaglutide for 9 months with gastric pneumatosis. Symptoms resolved on discontinuation. Clinicians should be vigilant for significant gastrointestinal adverse effects, including pneumatosis with semaglutide use.

查看原文本刊更多论文

塞马鲁肽是一种胰高血糖素样肽-1受体激动剂，用于治疗2型糖尿病，最近又用于减肥，但经常会引起胃肠道不良反应，如胃排空延迟和腹部不适。目前的文献尚未描述过与使用塞马鲁肽相关的胃气胀病例。我们报告了一名服用塞马鲁肽 9 个月的 61 岁男性的胃气胀病例。停药后症状缓解。临床医生应警惕严重的胃肠道不良反应，包括使用塞马鲁肽引起的气胸。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACG Case Reports Journal GASTROENTEROLOGY & HEPATOLOGY-

自引率

14.30%

发文量

170

审稿时长

12 weeks

期刊介绍： ACG Case Reports Journal is a peer-reviewed, open-access publication that provides GI and hepatology fellows, private practice clinicians, and other healthcare providers an opportunity to share interesting case reports with their peers and with leaders in the field. ACG Case Reports Journal publishes case reports, images, videos and letters to the editor in all topics of gastroenterology and hepatology, including: Biliary Colon Endoscopy Esophagus Functional Bowel Disorders Inflammatory Bowel Disease Liver Nutrition and Obesity Pancreas Pathology Pediatric Small Bowel Stomach.